Launch of deep technology incubator
This week ANSTO formally launched the nandin Deep Technology Incubator, a full-service innovation hub that enables the best and the brightest minds to come together to foster innovation and change.
Showing 41 - 60 of 251 results
This week ANSTO formally launched the nandin Deep Technology Incubator, a full-service innovation hub that enables the best and the brightest minds to come together to foster innovation and change.
This scholarship recognises outstanding ability and promise in the field of nuclear science and technology, specifically as it applies to nuclear energy. Successful applicants will demonstrate a history of interest in nuclear energy and a desire to continue this interest.
Shift in the treatment of blood cancers taking place.
ANSTO today welcomed a significant Federal Government funding allocation to further safeguard the production of life-saving nuclear medicines in Australia.
ANSTO physicist supports launch of new carbon ion therapy treatment service in Austria.
Letter to Editor of the Sydney Morning Herald following publication of news report
The final report on the safety of Building 23 by the independent expert review team has been completed.
Research confirms that methylcellulose, one of the most widely used hydrogel-forming materials in biomedical research and consumer products, organises itself into a structural architecture
ANSTO has been tracking and publishing data on fine particle pollution from key sites around Australia, and internationally, for more than 20 years.
ANSTO recognises local Indigenous heritage in new mural
ANSTO will make an application to the independent nuclear regulator, ARPANSA, to vary its license for its Interim Waste Store. The original operating license was approved in 2015, enabling the facility to hold what is called a TN-81 cask of intermediate-level radioactive waste that was safely repatriated from France in 2015.
Scientists from the Walter and Eliza Hall Institute (WEHI) are using the unique immune system of the alpaca and techniques at the Australian Synchrotron as part of research using antibodies to disrupt COVID-19 viral entry into cells.
See details of previously published customer updates from our Health products team.
Ongoing media statements relating to nuclear medicine production.